CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
Authors
Keywords
Cancer treatment, Ovarian cancer, Chemokines, Angiogenesis, Tumor angiogenesis, Cytokines, Mouse models, Growth factors
Journal
PLoS One
Volume 10, Issue 9, Pages e0139237
Publisher
Public Library of Science (PLoS)
Online
2015-09-29
DOI
10.1371/journal.pone.0139237
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone regeneration using an alpha 2 beta 1 integrin-specific hydrogel as a BMP-2 delivery vehicle
- (2014) Asha Shekaran et al. BIOMATERIALS
- Modified β-Cyclodextrin Inclusion Complex to Improve the Physicochemical Properties of Albendazole. Complete In Vitro Evaluation and Characterization
- (2014) Agustina García et al. PLoS One
- Semaphorin7A promotes tumor growth and exerts a pro-angiogenic effect in macrophages of mammary tumor-bearing mice
- (2014) Ramon Garcia-Areas et al. Frontiers in Physiology
- Endurance Exercise Training Improves Heart Rate Recovery in Patients with COPD
- (2013) Elena Gimeno-Santos et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Angiogenesis as a target for the treatment of ovarian cancer
- (2013) Danielle Shaw et al. CURRENT OPINION IN ONCOLOGY
- Selection of native freshwater microalgae and cyanobacteria for CO2biofixation
- (2013) L. Martínez et al. ENVIRONMENTAL TECHNOLOGY
- Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma—Mechanistics, review of phase III randomized clinical trials, and regulatory implications
- (2013) Ramez N. Eskander et al. GYNECOLOGIC ONCOLOGY
- Diffusible Signal Factor (DSF) Synthase RpfF of Xylella fastidiosa Is a Multifunction Protein Also Required for Response to DSF
- (2013) M. Ionescu et al. JOURNAL OF BACTERIOLOGY
- Olmsted syndrome: exploration of the immunological phenotype
- (2013) Dina Danso-Abeam et al. Orphanet Journal of Rare Diseases
- Mice Deficient in the Respiratory Chain Gene Cox6a2 Are Protected against High-Fat Diet-Induced Obesity and Insulin Resistance
- (2013) Roel Quintens et al. PLoS One
- High-resolution reversible folding of hyperstable RNA tetraloops using molecular dynamics simulations
- (2013) A. A. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients
- (2012) A. W. Griffioen et al. CLINICAL CANCER RESEARCH
- Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion
- (2012) Yue Wang et al. CYTOKINE
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2011) Yue Wang et al. CYTOKINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma
- (2010) Brian I. Rini et al. CANCER
- Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2
- (2010) Yuxian Huang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A novel role for TNFAIP2: its correlation with invasion and metastasis in nasopharyngeal carcinoma
- (2010) Lih-Chyang Chen et al. MODERN PATHOLOGY
- Angiogenesis and ovarian cancer
- (2009) César Gómez-Raposo et al. Clinical & Translational Oncology
- Spheroid-based drug screen: considerations and practical approach
- (2009) Juergen Friedrich et al. Nature Protocols
- Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)
- (2008) Axel Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
- The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice
- (2008) Allisson Freire Bento et al. JOURNAL OF LEUKOCYTE BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started